About Nicholas Tritos, MD, DSC

Dr. Tritos is a staff neuroendocrinologist in the Neuroendocrine and Pituitary Tumor Clinical Center and a faculty member in the Neuroendocrine Unit at the Massachusetts General Hospital. He serves as an Associate Professor of Medicine at Harvard Medical School. He also conducts clinical research with a focus on pituitary tumors and growth hormone deficiency in adults. He is the author or co-author of more than 130 peer-reviewed publications in endocrinology, and an associate editor, editorial board member and regular peer-reviewer for professional journals. He has been regularly serving on professional and scientific committees (Endocrine Society, Pituitary Society and AACE).

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Languages:

Locations

Mass General Endocrinology: Neuroendocrine & Pituitary Tumor Clinical Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-7948

Medical Education

  • MD, University of Athens School of Medicine
  • Residency, New England Deaconess Hospital
  • Fellowship, Beth Israel Deaconess Hospital

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Tritos conducts clinical research with a focus on pituitary tumors and growth hormone deficiency in adults. He is the author or co-author of more than 130 peer-reviewed publications in the field of endocrinology, associate editor, editorial board member and a regular peer-reviewer for professional Journals.

Publications

  • N.A. Tritos, P.W. Schaefer, T.D. Stein. Case records of the Massachusetts General Hospital. A 52 year old man with weakness, infections, and enlarged adrenal glands. NEJM 2011; 365: 2520-2530.

    N.A. Tritos, S.L. Greenspan, D. King, A. Hamrahian, D.M. Cook, P.J. Jönsson, M.P. Wajnrajch, Maria Koltowska – Häggstrom, B.M.K. Biller. Unreplaced sex steroid deficiency, corticotropin deficiency and lower IGF-1 are associated with lower bone mineral density in adults with growth hormone deficiency. JCEM 2011; 96: 1516- 1523.

    P.B. Silva PB, F.G. Amlashi, E.W. Yu, K.J. Pulaski-Liebert, A.V. Gerweck, P.K. Fazeli, E. Lawson, L.B. Nachtigall, B.M.K. Biller, K.K. Miller, A. Klibanski, M. Bouxsein, N.A. Tritos. Bone microarchitecture and estimated bone strength in men with active acromegaly. EJE 2017; 177: 409-420.

    N. Qiao, B. Swearingen, N.A. Tritos. Cushing's disease in older adults: presentation and outcome. Clin Endocrinol 2018; 89: 444-453.

    B.P. Galm, E.L. Martinez-Salazar, B. Swearingen, M. Torriani, A. Klibanski, M.A. Bredella, N.A. Tritos. MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. EJE 2018; 191-198.

    A. Faje, K. Reynolds, L. Zubiri, D. Lawrence, J. Cohen, R. Sullivan, L. Nachtigall, N.A. Tritos. Hypophysitis secondary to nivolumab and pembrolizumab is distinct from ipilimumab-associated hypophysitis. EJE 2019 Jun 1. pii: EJE-19-0238.R1. doi: 10.1530/EJE-19-0238.

    B.P. Galm, N. Qiao, A. Klibanski, B.M.K. Biller, N.A. Tritos. Accuracy of laboratory tests for the diagnosis of Cushing's syndrome. JCEM 2020; 105: 2081-2094.

Reviews: Comments and Ratings